Why is Remedium Life falling/rising?

As of 01-Jul, Remedium Lifecare Ltd's stock price is currently at 1.02, reflecting an increase of 0.04 or 4.08%. The stock has shown a strong performance recently, gaining 21.43% over the past week, although it has experienced significant declines over the longer term, with a year-to-date drop of 71.46% and a staggering 91.90% decline over the past year. Today's performance indicates that the stock has outperformed its sector by 4.94%, and it has been on a consecutive gain streak for the last five days. However, despite this recent uptick, the stock's delivery volume has decreased significantly, falling by 67.65% against the five-day average, indicating a potential decline in investor participation. Additionally, the company faces serious financial challenges, including a high Debt to EBITDA ratio of -1.00 times and negative returns on capital employed (ROCE), which suggest a low ability to service debt and poor long-term growth prospects. In the broader market context, the stock's recent short-term return of 21.43% over the past week stands in stark contrast to the Sensex, which has only increased by 2.00% during the same period. However, the long-term performance remains concerning, as the stock has underperformed the benchmark significantly over one year and three years. The company's negative financial results, including a 94.11% fall in profit before tax and a 96.31% decline in profit after tax, further exacerbate the situation, leading to a perception of risk among investors. Overall, while the recent price increase may suggest a temporary rebound, the underlying financial instability and poor long-term growth prospects indicate that the stock remains a risky investment.